Agarwal Arjun's Form 4 filing
Oruka Therapeutics, Inc. (ORKA) · filed May 18, 2026
- Accession no.
- 0000907654-26-000041
- Filed
- May 18, 2026
- Trade date
- May 18, 2026
- Filing delay
- Same day
- Rule 10b5-1 plan
- Checked
This filing lists 6 non-derivative transactions and 2 derivative transactions. Open-market sales total $607.8K. It was filed on the trade date.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Agarwal ArjunCIK 0002033974 | Officer (Senior Vice President, Finance) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 18, 2026 | Common Stock | MOption exerciseAcquired | +2,000 | $12.50 | +$25,000 | 20,863 | Direct | |
| May 18, 2026 | Common Stock | MOption exerciseAcquired | +5,833 | $34.39 | +$200,596.87 | 26,696 | Direct | |
| May 18, 2026 | Common Stock | SSaleDisposed | −4,190 | $58.34 | −$244,444.6 | 22,506 | Direct | |
| May 18, 2026 | Common Stock | SSaleDisposed | −4,600 | $59.19 | −$272,274 | 17,906 | Direct | |
| May 18, 2026 | Common Stock | SSaleDisposed | −800 | $60.34 | −$48,272 | 17,106 | Direct | |
| May 18, 2026 | Common Stock | SSaleDisposed | −700 | $61.16 | −$42,812 | 16,406 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 18, 2026 | Common Stock | MOption exerciseDisposed | −2,000 | $0.00 | $0 | 118,000 | Direct | |
| May 18, 2026 | Common Stock | MOption exerciseDisposed | −5,833 | $0.00 | $0 | 64,167 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.